Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions
Peter Valent, Cem Akin, Patrizia Bonadonna, Knut Brockow, Marek Niedoszytko, Bogusław Nedoszytko, Joseph H. Butterfield, Iván Álvarez‐Twöse, Karl Sotlar, Juliana Schwaab, Mohamad Jawhar, Andreas Reiter, Mariana Castells, Wolfgang R. Sperr, Hanneke C. Kluin‐Nelemans, Olivier Hermine, Jason Gotlib, Roberta Zanotti, Sigurd Broesby‐Olsen, Hans-Peter Horny, Massimo Triggiani, Frank Siebenhaar, Alberto Órfão, Dean D. Metcalfe, Michel Arock, Karin Hartmann
Topics & Concepts
Coronavirus disease 2019 (COVID-19)PandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyMedicineInternal medicineInfectious disease (medical specialty)OutbreakDiseaseMast cells and histamineImmune responses and vaccinationsDrug-Induced Adverse Reactions